MedTrace Logo

Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid Hemorrhage

NCT02350335 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-04-12

No results posted yet for this study

Summary

All patients with acute aneurysmal hemorrhage are treated in accordance with our institutional protocol. After securing of the aneurysm, some smokers with acute aneurysmal hemorrhage are randomly assigned to transdermal nicotine replacement (NRT). The short- and long-term effect of NRT will be studied comparing non-smokers, smokers without NRT and smokers with NRT.

Conditions

  • Aneurysmal Subarachnoid Hemorrhage

Interventions

DRUG

Nicotine (transdermal)

Application of transdermal nicotine replacement in smokers with acute aneurysmal hemorrhage

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Angelika G Sorteberg, MD, PhD · Consulting neurosurgeon, Head of division Rikshospitalet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02350335 on ClinicalTrials.gov